awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39095394-9B6E650B-4108-4A30-A760-5CB113B53D32
Q39095394-9B6E650B-4108-4A30-A760-5CB113B53D32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39095394-9B6E650B-4108-4A30-A760-5CB113B53D32
Trends in celecoxib and etoricoxib prescribing following removal of prior authorization requirement in Spain.
P2860
Q39095394-9B6E650B-4108-4A30-A760-5CB113B53D32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39095394-9B6E650B-4108-4A30-A760-5CB113B53D32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2eaefaaee30e6be9ea0e209727997e629657f7f0
P2860
Differential effect of early or late implementation of prior authorization policies on the use of Cox II inhibitors.